Recent Updates
Recently added Catalysts
DMAC Positive Sentiment

DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019

Key Takeaway: DiaMedica Therapeutics Inc. will release its first quarter 2019 financial results on May 13, 2019, after market close. A conference call is scheduled for May 14, 2019, at 7:00 am CT, where management will discuss the financial results and provide a business update. The call will be available for playback on their website.

Market Sentiment Analysis

POSITIVE FACTORS

  • DiaMedica is actively engaging with investors through a conference call.
  • The company is focused on developing treatments for significant health issues.
  • The upcoming financial results may provide insights into the company's progress.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~16 mo
Low dilution risk
Lead asset
Recombinant human tissue kallikrein
Phase 2 · Acute Ischemic Stroke

Full Press Release Details

MINNEAPOLIS, May 06, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its first quarter 2019 financial results will be released after market close on Monday, May 13th.  DiaMedica’s management will host a live conference call on Tuesday, May 14that 7:00am Central Time to provide a business update and discuss the Company’s financial results.
Conference Call details:
Date: Tuesday, May 14, 2019
Time: 7:00 AM CT
Web access: https://edge.media-server.com/m6/p/qrb8q6a5
Dial In: (866) 962-3583 (domestic)
(630) 652-5857 (international)
Conference ID: 8177137
Listeners should log on to the website or dial in 15 minutes prior to the call.  The webcast will remain available for play back on our website, under investor events and presentations, following the earnings call and for 12 months thereafter. A telephonic replay of the conference call will be available until May 21, 2019, by dialing 1(855) 859-2056 (US Toll Free Dial In), (404) 537-3406 (international), replay passcode 8177137.
About DiaMedica Therapeutics Inc.DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company focused on developing novel treatments for chronic kidney diseases and neurological disorders. DiaMedica’s shares are listed on The Nasdaq Capital Market under the trading symbol “DMAC.”
For more information, please visitwww.diamedica.comor follow us onTwitter.

Frequently Asked Questions

When will DiaMedica report its Q1 2019 financial results?

DiaMedica will release its Q1 2019 financial results on May 13, 2019.

What time is the DiaMedica conference call?

The conference call is scheduled for May 14, 2019, at 7:00 am Central Time.

How can I access the DiaMedica conference call?

Listeners can log on to the website or dial in 15 minutes prior to the call.

What is DiaMedica focused on developing?

DiaMedica is focused on developing treatments for chronic kidney diseases and neurological disorders.

Last updated: May 6, 2019